Right Ventricular Involvement in Diabetic Cardiomyopathy

por Widya, Ralph L., van der Meer, Rutger W., Smit, Johannes W.A., Rijzewijk, Luuk J., Diamant, Michaela, Bax, Jeroen J., de Roos, Albert, Lamb, Hildo J.
Publicado 2013

Pioglitazone alters fat distribution in patients with type 2 diabetes mellitus, in contrast to metformin

por Jonker, Jacqueline T, van der Meer, Rutger W, Rijzewijk, Luuk J, Menting, Lisa M, Diamant, Michaela, Romijn, Johannes A, Smit, Johannes WA, de Roos, Albert, Lamb, Hildo J
Publicado 2009

Fatty liver in uncomplicated type 2 DM is associated with impaired myocardial HEP metabolism, modulated by myocardial glucose uptake

por Jonker, Jacqueline T, Meer, Rutger W van der, Rijzewijk, Luuk J, Lammertsma, Adriaan A, Diamant, Michaela, Smit, Johannes WA, de Roos, Albert, Romijn, Johannes A, Lamb, Hildo J
Publicado 2009

Liver Fat Content in Type 2 Diabetes: Relationship With Hepatic Perfusion and Substrate Metabolism

por Rijzewijk, Luuk J., van der Meer, Rutger W., Lubberink, Mark, Lamb, Hildo J., Romijn, Johannes A., de Roos, Albert, Twisk, Jos W., Heine, Robert J., Lammertsma, Adriaan A., Smit, Johannes W.A., Diamant, Michaela
Publicado 2010

Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes

por Jonker, Jacqueline T., Wang, Yanan, de Haan, Willeke, Diamant, Michaela, Rijzewijk, Luuk J., van der Meer, Rutger W., Lamb, Hildo J., Tamsma, Jouke T., de Roos, Albert, Romijn, Johannes A., Rensen, Patrick C.N., Smit, Johannes W.A.
Publicado 2010

Activin a is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes

por Chen, Weena JY, Greulich, Sabrina, van der Meer, Rutger W, Rijzewijk, Luuk J, Lamb, Hildo J, de Roos, Albert, Smit, Johannes WA, Romijn, Johannes A, Ruige, Johannes B, Lammertsma, Adriaan A, Lubberink, Mark, Diamant, Michaela, Ouwens, D Margriet
Publicado 2013

Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men

por Chen, Weena JY, Rijzewijk, Luuk J, van der Meer, Rutger W, Heymans, Martijn W, van Duinkerken, Eelco, Lubberink, Mark, Lammertsma, Adriaan A, Lamb, Hildo J, de Roos, Albert, Romijn, Johannes A, Smit, Jan WA, Bax, Jeroen J, Bjerre, Mette, Frystyk, Jan, Flyvbjerg, Allan, Diamant, Michaela
Publicado 2011

Cardioprotective Properties of Omentin-1 in Type 2 Diabetes: Evidence from Clinical and In Vitro Studies

por Greulich, Sabrina, Chen, Weena J. Y., Maxhera, Bujar, Rijzewijk, Luuk J., van der Meer, Rutger W., Jonker, Jacqueline T., Mueller, Heidi, de Wiza, Daniella Herzfeld, Floerke, Ralf-Ruediger, Smiris, Konstantinos, Lamb, Hildo J., de Roos, Albert, Bax, Jeroen J., Romijn, Johannes A., Smit, Jan W. A., Akhyari, Payam, Lichtenberg, Artur, Eckel, Juergen, Diamant, Michaela, Ouwens, D. Margriet
Publicado 2013